ePrints

Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO

Lookup NU author(s): Professor Pat Kendall-Taylor, Dr Petros PerrosORCiD, Christopher Neoh, Professor Simon PearceORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

a. All patients with GO should (Fig. 1): Be referred to specialist centers; Be encouraged to quit smoking; Receive prompt treatment in order to restore and maintain euthyroidism. b. Patients with sight-threatening GO should be treated with i.v. GCs as the first-line treatment; if the response is poor after 1-2 weeks, they should be submitted to urgent surgical decompression. c. The treatment of choice for moderate-to-severe GO is i.v. GCs (with or without OR) if the orbitopathy is active; surgery (orbital decompression, squint surgery, and/or eyelid surgery in this order) should be considered if the orbitopathy is inactive. d. In patients with mild GO, local measures and an expectant strategy are sufficient in most cases, but treatment may be justified if QoL is affected significantly. © 2008 Society of the European Journal of Endocrinology.

Publication metadata

Author(s): Bartalena L, Baldeschi L, Dickinson A, Eckstein A, Kendall-Taylor P, Marcocci C, Mourits M, Perros P, Boboridis K, Boschi A, Curro N, Daumerie C, Kahaly GJ, Krassas GE, Lane CM, Lazarus JH, Marino M, Nardi M, Neoh C, Orgiazzi J, Pearce S, Pinchera A, Pitz S, Salvi M, Sivelli P, Stahl M, von Arx G, Wiersinga WM

Publication type: Article

Publication status: Published

Journal: European Journal of Endocrinology

Year: 2008

Volume: 158

Issue: 3

Pages: 273-285

ISSN (print): 0804-4643

ISSN (electronic): 1479-683X

Publisher: BioScientifica Ltd.

URL: http://dx.doi.org/10.1530/EJE-07-0666

DOI: 10.1530/EJE-07-0666

PubMed id: 18299459

Altmetrics

Share